Trial intelligence / Profile preview

DOLVAX: Buzzy® Device vs EMLAPATCH for Pediatric Pain Prevention

NCT03220555Completed

Sponsor
CHU de Nantes
Start
Oct 2017
Primary completion
Sep 2018
Countries
1
01

Overview

Randomised, open-label trial in procedural pain (2 arms), sponsored by CHU de Nantes. Primary endpoint: Faces Pain Scale revised for children at Day 0. Started Oct 2017; status: completed.

02

Conditions

procedural pain

Beyond the preview

Go deeper on NCT03220555.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03220555.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call